Correcting for bias when estimating the cost of hospital-acquired infection: an analysis of lower respiratory tract infections in non-surgical patients.
Hospital acquired infections (HAI) are costly but many are avoidable. Evaluating prevention programmes requires data on their costs and benefits. Estimating the actual costs of HAI (a measure of the cost savings due to prevention) is difficult as HAI changes cost by extending patient length of stay, yet, length of stay is a major risk factor for HAI. This endogeneity bias can confound attempts to measure accurately the cost of HAI. We propose a two-stage instrumental variables estimation strategy that explicitly controls for the endogeneity between risk of HAI and length of stay. We find that a 10% reduction in ex ante risk of HAI results in an expected savings of pound 693 ($ US 984).
Graves
Nicholas
N
Centre for Healthcare Related Infection, Surveillance and Prevention, Princess Alexandra Hospital, Queensland, Australia. n.graves@qut.edu.au
Weinhold
Diana
D
Roberts
Jennifer A
JA
D015982:Bias; D003362:Cost-Benefit Analysis; D003428:Cross Infection / Q000191:economics* / Q000453:epidemiology; D005260:Female; D017048:Health Care Costs; D006801:Humans; D007297:Inpatients; D007902:Length of Stay / Q000191:economics / Q000706:statistics & numerical data; D008297:Male; D018803:Models, Economic; D012141:Respiratory Tract Infections / Q000191:economics* / Q000453:epidemiology; D018570:Risk Assessment